This report is a review of recent and emerging trends that promise to make radiation oncology for prostate cancer more efficient, effective, and patient-friendly.
New clinical candidate targeting PRAME Preferentially Expressed Antigen in Melanoma (PRAME) is a tumor-specific therapeutic target that is expressed in a wide range of solid tumors including lung ...
Prostate-specific antigen (PSA) blood test. This test measures the level of PSA in your blood. A high level may be a sign of prostate cancer. Not all medical institutions agree on when you should ...
New clinical candidate targeting PRAME Preferentially Expressed Antigen in Melanoma (PRAME) is a tumor-specific therapeutic target that is expressed in a wide range of solid tumors including lung ...